Investor
Bratton Capital Management, L.P.
CIK 0001723787 · filed 2026-05-13 · SEC filing
13F book
$40.7M
Positions
1
Largest name
100.0%
Aquestive Therapeutics, Inc. · AQST
Est. mark
−$22.7M
Price effect on 1 names still held. Flow $0.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | AQST | 9.81M | $40.7M | 100.0% | −$22.7M | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.